Insulin Resistance in Adults Infected With HIV
Insulin resistance has been identified as a key driver of CVD and other complications in people living with HIV.
Diabetes
Direct-Acting Agents for Hepatitis C Reduce Risk for Incident Diabetes
In a large cohort of patients with HCV, the use of DAA was associated with significantly lower incidence and risk for subsequent diabetes.
Significant Risk for Severe TB and CVD in Patients With Comorbid TB/Diabetes
The majority of cases of diabetes in patients with tuberculosis are diagnosed, but are poorly controlled in 4 TB-endemic countries.
INF Treatment Lowers Risk for Diabetes and Mortality in HIV/HCV Coinfection
Sustained virologic response to the HCV in patients with HCV and HIV coinfection is associated with a lowered risk of diabetes and mortality.
Helicobacter pylori Infection Linked to Elevated Risk for Diabetes in Men
Helicobacter pylori infection is associated with a higher risk for type 2 diabetes developing.
Age, Exposure to Antiretrovirals Affect Diabetes Risk in HIV
Interventions for diabetes prevention and management may be needed to reduce the risk for diabetes in patients with HIV.
Rising Incidence of Diabetes in Adults With HIV on Antiretroviral Therapy
More research is needed to better capture the interplay between prediabetes/diabetes and antiretroviral therapy in people with HIV.
Omadacycline Noninferior to Linezolid in ABSSSI Patients With High BMI, Diabetes
The goal of this post-hoc analysis of OASIS-1 study was to determine if BMI or T2D had any effect on the efficacy or safety of omadacycline relative to linezolid.
Treating ABSSSI in Diabetes: Efficacy of Dalbavancin Examined
Dalbavancin has shown potent activity against gram-positive pathogens responsible for ABSSSI, including MRSA.
Metformin Reduces Mortality During Tuberculosis Therapy
Researchers assess all-cause mortality during tuberculosis treatment in patients with diabetes, the use of metformin, and effect sputum culture-conversion rates.
